FR17C1020I1 - - Google Patents

Info

Publication number: FR17C1020I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-16

Filing date

2017-06-06

Publication date

2020-04-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39717519&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR17C1020(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-06-06 Application filed filed Critical

2020-04-10 Application granted granted Critical

2020-04-10 Publication of FR17C1020I1 publication Critical patent/FR17C1020I1/fr

2020-04-10 Publication of FR17C1020I2 publication Critical patent/FR17C1020I2/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C12Y204/99006—N-Acetyllactosaminide alpha-2,3-sialyltransferase (2.4.99.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FR17C1020C 2008-04-16 2017-06-06 Fsh recombinante comprenant la sialylation alpha 2,3 et alpha 2,6 Active FR17C1020I2 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4542408P	2008-04-16	2008-04-16
EP08251528		2008-04-25
EP09733497.3A EP2268666B1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
EP13193214.7A EP2722339A1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
EP14178729.1A EP2808340B1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation

Publications (2)

Publication Number	Publication Date
FR17C1020I1 true FR17C1020I1 (ru)	2020-04-10
FR17C1020I2 FR17C1020I2 (fr)	2020-04-10

Family

ID=39717519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR17C1020C Active FR17C1020I2 (fr)	2008-04-16	2017-06-06	Fsh recombinante comprenant la sialylation alpha 2,3 et alpha 2,6

Country Status (29)

Country	Link
US (5)	US8951967B2 (ru)
EP (7)	EP2268666B1 (ru)
JP (7)	JP2011519359A (ru)
KR (5)	KR20160056960A (ru)
CN (3)	CN105906703A (ru)
AR (1)	AR071479A1 (ru)
AU (5)	AU2009237479B2 (ru)
BR (1)	BRPI0910461B8 (ru)
CA (1)	CA2725257A1 (ru)
CY (1)	CY1115413T1 (ru)
DK (4)	DK3045471T3 (ru)
ES (3)	ES2610277T3 (ru)
FR (1)	FR17C1020I2 (ru)
HK (2)	HK1146284A1 (ru)
HR (3)	HRP20140535T1 (ru)
HU (5)	HUE030652T4 (ru)
IL (2)	IL208538A (ru)
LT (4)	LT3045471T (ru)
MX (3)	MX348622B (ru)
NO (2)	NO2017025I1 (ru)
NZ (1)	NZ588381A (ru)
PL (4)	PL3144318T3 (ru)
PT (4)	PT3045471T (ru)
RU (3)	RU2537268C2 (ru)
SA (1)	SA109300228B1 (ru)
SI (4)	SI3045471T1 (ru)
TW (1)	TWI488640B (ru)
WO (1)	WO2009127826A1 (ru)
ZA (1)	ZA201007373B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (zh)	2008-04-16	2015-06-21	Ferring Int Ct Sa	藥學製劑
TWI604850B (zh) *	2009-10-05	2017-11-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
FI2621517T4 (fi)	2010-09-29	2024-01-03	Ferring Bv	Koostumus käytettäväksi hedelmättömyyden hoidossa
CN103154243A (zh)	2010-10-15	2013-06-12	日本化学研究株式会社	糖链的非还原末端为甘露糖残基的糖蛋白的制造方法
CA3163525A1 (en)	2011-03-31	2012-10-04	Ferring Bv.	Pharmaceutical preparation
WO2012168680A1 (en)	2011-06-06	2012-12-13	Ferring B.V.	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar)	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
AU2012340501A1 (en) *	2011-12-19	2013-07-11	Grifols, S.A.	Compositions, methods, and kits for preparing sialylated recombinant proteins
JP6279466B2 (ja) *	2012-04-27	2018-02-14	Ｊｃｒファーマ株式会社	新規な発現ベクター
EP2824176A1 (en)	2013-07-11	2015-01-14	Siamed'xpress	Methods for producing sialylated therapeutic proteins
JP6652334B2 (ja) *	2014-05-31	2020-02-19	Ｊｃｒファーマ株式会社	ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
JP2018500934A (ja) *	2014-12-22	2018-01-18	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	Ｃｍｐ依存性シアリダーゼ活性
CN107405385A (zh)	2015-04-17	2017-11-28	辉凌公司	用于治疗不育的组合物
ES2770860T3 (es)	2015-06-26	2020-07-03	Ferring Bv	Métodos de purificación y/o inactivación viral
EP3205719A1 (en) *	2016-02-15	2017-08-16	CEVEC Pharmaceuticals GmbH	Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins
GB201603280D0 (en)	2016-02-24	2016-04-13	Ferring Bv	Stable liquid gonadotropin formulation
EP3382014A1 (en) *	2017-03-29	2018-10-03	CEVEC Pharmaceuticals GmbH	Recombinant glycoproteins with reduced antennary fucosylation
EP3441471A1 (en)	2017-08-08	2019-02-13	CEVEC Pharmaceuticals GmbH	Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines
RS62810B1 (sr)	2017-09-01	2022-02-28	Ferring Bv	Kompozicija za kontrolisanu stimulaciju jajnika
WO2019211153A1 (en)	2018-04-30	2019-11-07	Ferring B.V.	Composition for controlled ovarian stimulation
JOP20210025A1 (ar)	2018-10-17	2021-02-07	Ferring Bv	تركيبات وطرق للتنشيط المتحكم فيه للمبيض
WO2021081670A1 (en) *	2019-11-01	2021-05-06	The University Of British Columbia	Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
TW202237173A (zh)	2020-12-09	2022-10-01	荷蘭商菲林公司	用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en)	2022-04-01	2023-10-05	Ferring B.V.	Mixed protocol for treatment of infertility
WO2023227761A1 (en)	2022-05-26	2023-11-30	Ferring B.V.	Compositions and methods for treatment of infertility in males
WO2024008971A1 (en)	2022-07-08	2024-01-11	Ferring B.V.	Compositions and methods for intrauterine insemination (iui)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1206302B (it)	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	Ormone follicolo-stimolante urinario
US5541083A (en)	1989-10-24	1996-07-30	The Regents Of The University Of California	Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5994128A (en)	1995-06-15	1999-11-30	Introgene B.V.	Packaging systems for human recombinant adenovirus to be used in gene therapy
JP3559652B2 (ja) *	1996-06-25	2004-09-02	グローリー工業株式会社	売上精算システムの管理装置
TW518235B (en) *	1997-01-15	2003-01-21	Akzo Nobel Nv	A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
DE69823046T2 (de)	1997-01-16	2005-03-31	Neose Technologies, Inc.	Praktische in vitro sialylierung von rekombinanten glykpproteinen
JPH1111665A (ja)	1997-06-28	1999-01-19	Shibuya Kogyo Co Ltd	無菌エア搬送コンベヤ装置
TWI235158B (en) *	1997-09-01	2005-07-01	Kirin Brewery	Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
AU4592800A (en)	1999-05-07	2000-11-21	Applied Research Systems Ars Holding N.V.	Gonadotrophins
JP2002011665A (ja)	2000-06-28	2002-01-15	Sintokogio Ltd	ショットブラスト装置モニタシステム
IL140110A0 (en) *	2000-12-05	2002-02-10	Applied Research Systems	Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
DK1438336T3 (da) *	2001-10-22	2006-10-02	Applied Research Systems	Gonadotropiner til follikeldannelse
CA2756610C (en)	2001-10-29	2015-08-25	Crucell Holland B.V.	Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures
CA2468957C (en)	2001-12-07	2011-07-12	Crucell Holland B.V.	Methods of propagation of influenza virus in cell lines over expressing sialyl transferases
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
JP2007515410A (ja) *	2003-12-03	2007-06-14	ネオステクノロジーズインコーポレイテッド	ＧｌｙｃｏＰＥＧ化卵胞刺激ホルモン
US8431355B2 (en)	2004-02-04	2013-04-30	Universite De Provence Aix-Marseille 1	Process for screening glycoform-specific antibodies
WO2005080585A1 (en)	2004-02-13	2005-09-01	Glycotope Gmbh	Highly active glycoproteins-process conditions and an efficient method for their production
TWI488640B (zh)	2008-04-16	2015-06-21	Ferring Int Ct Sa	藥學製劑
TWI604850B (zh)	2009-10-05	2017-11-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
EP2600809B1 (en)	2010-08-03	2015-02-25	King Saud University	Stoma coat
WO2012016576A1 (en)	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
FI2621517T4 (fi)	2010-09-29	2024-01-03	Ferring Bv	Koostumus käytettäväksi hedelmättömyyden hoidossa
CA3163525A1 (en)	2011-03-31	2012-10-04	Ferring Bv.	Pharmaceutical preparation
WO2012168680A1 (en)	2011-06-06	2012-12-13	Ferring B.V.	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar)	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
US20170035854A1 (en)	2014-04-18	2017-02-09	Glycotope Gmbh	Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

2009
- 2009-04-15 TW TW098112483A patent/TWI488640B/zh active
- 2009-04-16 KR KR1020167012148A patent/KR20160056960A/ko not_active Application Discontinuation
- 2009-04-16 EP EP09733497.3A patent/EP2268666B1/en not_active Revoked
- 2009-04-16 KR KR1020107025581A patent/KR101622944B1/ko active IP Right Grant
- 2009-04-16 EP EP21212873.0A patent/EP4015527A1/en active Pending
- 2009-04-16 CA CA2725257A patent/CA2725257A1/en active Pending
- 2009-04-16 DK DK16158141.8T patent/DK3045471T3/en active
- 2009-04-16 US US12/988,218 patent/US8951967B2/en active Active
- 2009-04-16 LT LTEP16158141.8T patent/LT3045471T/lt unknown
- 2009-04-16 PT PT161581418T patent/PT3045471T/pt unknown
- 2009-04-16 NZ NZ588381A patent/NZ588381A/en unknown
- 2009-04-16 CN CN201510933827.2A patent/CN105906703A/zh active Pending
- 2009-04-16 PL PL16194925T patent/PL3144318T3/pl unknown
- 2009-04-16 EP EP16158141.8A patent/EP3045471B1/en not_active Revoked
- 2009-04-16 HU HUE14178729A patent/HUE030652T4/en unknown
- 2009-04-16 CN CN201510933782.9A patent/CN105906702A/zh active Pending
- 2009-04-16 EP EP16179121.5A patent/EP3098234B1/en active Active
- 2009-04-16 DK DK14178729.1T patent/DK2808340T3/en active
- 2009-04-16 MX MX2014011348A patent/MX348622B/es unknown
- 2009-04-16 EP EP14178729.1A patent/EP2808340B1/en not_active Revoked
- 2009-04-16 ES ES14178729.1T patent/ES2610277T3/es active Active
- 2009-04-16 KR KR1020187023820A patent/KR20180095140A/ko active Application Filing
- 2009-04-16 MX MX2010011343A patent/MX2010011343A/es active IP Right Grant
- 2009-04-16 SI SI200931670A patent/SI3045471T1/sl unknown
- 2009-04-16 HU HUE16158141A patent/HUE033830T2/en unknown
- 2009-04-16 RU RU2010141908/10A patent/RU2537268C2/ru active
- 2009-04-16 CN CN200980121391XA patent/CN102066414A/zh active Pending
- 2009-04-16 MX MX2017007881A patent/MX355457B/es unknown
- 2009-04-16 RU RU2014141994A patent/RU2682270C2/ru active
- 2009-04-16 AU AU2009237479A patent/AU2009237479B2/en active Active
- 2009-04-16 KR KR1020197022294A patent/KR102108377B1/ko active IP Right Grant
- 2009-04-16 JP JP2011504527A patent/JP2011519359A/ja active Pending
- 2009-04-16 SI SI200932094T patent/SI3144318T1/sl unknown
- 2009-04-16 PT PT97334973T patent/PT2268666E/pt unknown
- 2009-04-16 LT LTEP14178729.1T patent/LT2808340T/lt unknown
- 2009-04-16 ES ES09733497.3T patent/ES2468318T3/es active Active
- 2009-04-16 SI SI200931547A patent/SI2808340T1/sl unknown
- 2009-04-16 SI SI200930931T patent/SI2268666T1/sl unknown
- 2009-04-16 DK DK09733497.3T patent/DK2268666T3/da active
- 2009-04-16 PT PT141787291T patent/PT2808340T/pt unknown
- 2009-04-16 EP EP16194925.0A patent/EP3144318B1/en active Active
- 2009-04-16 KR KR1020177026920A patent/KR20170110741A/ko not_active Application Discontinuation
- 2009-04-16 PL PL16158141T patent/PL3045471T3/pl unknown
- 2009-04-16 ES ES16158141.8T patent/ES2629392T3/es active Active
- 2009-04-16 PL PL09733497T patent/PL2268666T3/pl unknown
- 2009-04-16 WO PCT/GB2009/000978 patent/WO2009127826A1/en active Application Filing
- 2009-04-16 DK DK16194925.0T patent/DK3144318T3/da active
- 2009-04-16 EP EP13193214.7A patent/EP2722339A1/en active Pending
- 2009-04-16 AR ARP090101333A patent/AR071479A1/es not_active Application Discontinuation
- 2009-04-16 BR BRPI0910461A patent/BRPI0910461B8/pt active IP Right Grant
- 2009-04-16 PT PT161949250T patent/PT3144318T/pt unknown
- 2009-04-16 PL PL14178729T patent/PL2808340T3/pl unknown
- 2009-04-18 SA SA109300228A patent/SA109300228B1/ar unknown
2010
- 2010-10-07 IL IL208538A patent/IL208538A/en active Protection Beyond IP Right Term
- 2010-10-14 ZA ZA2010/07373A patent/ZA201007373B/en unknown
2011
- 2011-01-17 HK HK11100441.2A patent/HK1146284A1/xx unknown
2014
- 2014-01-21 IL IL230571A patent/IL230571A/en active IP Right Grant
- 2014-06-06 CY CY20141100402T patent/CY1115413T1/el unknown
- 2014-06-09 HR HRP20140535AT patent/HRP20140535T1/hr unknown
- 2014-06-17 AU AU2014203277A patent/AU2014203277C1/en active Active
- 2014-11-14 US US14/541,852 patent/US9546204B2/en active Active
- 2014-12-10 HK HK14112411.0A patent/HK1199039A1/xx unknown
- 2014-12-25 JP JP2014262056A patent/JP2015120696A/ja active Pending
2016
- 2016-08-16 US US15/238,362 patent/US9771407B2/en active Active
- 2016-10-07 JP JP2016198588A patent/JP6486310B2/ja active Active
- 2016-11-16 HR HRP20161520TT patent/HRP20161520T1/hr unknown
2017
- 2017-05-30 HU HUS1700024C patent/HUS1700024I1/hu unknown
- 2017-05-31 HU HUS1700025C patent/HUS1700025I1/hu unknown
- 2017-06-05 LT LTPA2017018C patent/LTPA2017018I1/lt unknown
- 2017-06-06 NO NO2017025C patent/NO2017025I1/no unknown
- 2017-06-06 FR FR17C1020C patent/FR17C1020I2/fr active Active
- 2017-06-23 AU AU2017204259A patent/AU2017204259B2/en active Active
- 2017-06-23 AU AU2017204258A patent/AU2017204258B2/en active Active
- 2017-06-26 HR HRP20170958TT patent/HRP20170958T1/hr unknown
- 2017-08-01 JP JP2017148823A patent/JP6762916B2/ja active Active
- 2017-08-29 US US15/690,061 patent/US10995128B2/en active Active
- 2017-09-05 AU AU2017225020A patent/AU2017225020B2/en active Active
- 2017-09-27 LT LTPA2017029C patent/LTPA2017029I1/lt unknown
- 2017-09-27 HU HUS1700036C patent/HUS1700036I1/hu unknown
- 2017-09-28 NO NO2017050C patent/NO2017050I1/no unknown
2018
- 2018-11-08 RU RU2018139379A patent/RU2745557C3/ru active Protection Beyond IP Right Term
2019
- 2019-10-25 JP JP2019194476A patent/JP7316905B2/ja active Active
2021
- 2021-04-30 US US17/246,348 patent/US11952407B2/en active Active
- 2021-10-27 JP JP2021175403A patent/JP2022031652A/ja active Pending
2023
- 2023-12-21 JP JP2023215339A patent/JP2024038000A/ja active Pending

Also Published As

Publication number	Publication date
LT3045471T (lt)	2017-07-10
JP2020040956A (ja)	2020-03-19
PT3045471T (pt)	2017-06-14
US10995128B2 (en)	2021-05-04
EP3098234A1 (en)	2016-11-30
IL230571A (en)	2015-11-30
JP2017060476A (ja)	2017-03-30
US20210332099A1 (en)	2021-10-28
RU2010141908A (ru)	2012-05-27
JP7316905B2 (ja)	2023-07-28
DK3045471T3 (en)	2017-06-26
HUS1700024I1 (hu)	2017-06-28
PT2808340T (pt)	2016-11-21
JP2022031652A (ja)	2022-02-22
RU2682270C2 (ru)	2019-03-18
KR20110005863A (ko)	2011-01-19
LT2808340T (lt)	2016-11-10
TW200948378A (en)	2009-12-01
PL2808340T3 (pl)	2017-02-28
US11952407B2 (en)	2024-04-09
DK2808340T3 (en)	2016-12-05
PL3144318T3 (pl)	2021-02-08
EP2268666B1 (en)	2014-03-12
CN105906702A (zh)	2016-08-31
RU2537268C2 (ru)	2014-12-27
AU2017204258A1 (en)	2017-07-20
EP2722339A1 (en)	2014-04-23
AU2014203277A1 (en)	2014-07-24
HRP20161520T1 (hr)	2016-12-30
CY1115413T1 (el)	2017-01-04
LTPA2017029I1 (lt)	2017-10-10
PT3144318T (pt)	2020-11-04
EP2268666A1 (en)	2011-01-05
HUS1700036I1 (hu)	2017-10-30
ZA201007373B (en)	2011-06-29
EP3045471A1 (en)	2016-07-20
SA109300228B1 (ar)	2014-04-08
ES2610277T3 (es)	2017-04-26
RU2014141994A (ru)	2016-05-10
RU2745557C1 (ru)	2021-03-29
NZ588381A (en)	2012-05-25
US20160347811A1 (en)	2016-12-01
SI2268666T1 (sl)	2014-07-31
HUE033830T2 (en)	2018-01-29
KR20190092608A (ko)	2019-08-07
AU2014203277B2 (en)	2017-04-06
EP3045471B1 (en)	2017-03-29
BRPI0910461A8 (pt)	2018-10-16
IL208538A (en)	2014-03-31
AU2017204259A1 (en)	2017-07-20
KR20160056960A (ko)	2016-05-20
AU2017225020A1 (en)	2017-09-28
PL3045471T3 (pl)	2017-10-31
AU2017225020B2 (en)	2019-11-14
EP2808340A1 (en)	2014-12-03
HK1199039A1 (en)	2015-06-19
AU2014203277C1 (en)	2017-07-27
JP2024038000A (ja)	2024-03-19
AU2009237479B2 (en)	2014-05-15
BRPI0910461A2 (pt)	2018-03-27
PT2268666E (pt)	2014-06-25
SI3144318T1 (sl)	2020-12-31
AR071479A1 (es)	2010-06-23
AU2017204258B2 (en)	2017-08-17
HUS1700025I1 (hu)	2017-06-28
CA2725257A1 (en)	2009-10-22
US20110105398A1 (en)	2011-05-05
RU2745557C3 (ru)	2021-12-10
JP2015120696A (ja)	2015-07-02
NO2017050I1 (no)	2017-09-28
CN102066414A (zh)	2011-05-18
US9771407B2 (en)	2017-09-26
JP6762916B2 (ja)	2020-09-30
IL208538A0 (en)	2010-12-30
KR101622944B1 (ko)	2016-05-23
KR102108377B1 (ko)	2020-05-08
MX2010011343A (es)	2011-01-20
HUE030652T4 (en)	2017-09-28
RU2014141994A3 (ru)	2018-05-28
NO2017025I1 (no)	2017-06-06
ES2468318T3 (es)	2014-06-16
LTPA2017018I1 (lt)	2017-06-26
SI2808340T1 (sl)	2016-12-30
AU2017204259B2 (en)	2017-08-17
ES2629392T3 (es)	2017-08-09
US20180079794A1 (en)	2018-03-22
KR20170110741A (ko)	2017-10-11
JP2018021037A (ja)	2018-02-08
SI3045471T1 (sl)	2017-07-31
HRP20140535T1 (hr)	2014-07-18
EP4015527A1 (en)	2022-06-22
AU2009237479A1 (en)	2009-10-22
DK2268666T3 (da)	2014-05-12
BRPI0910461B8 (pt)	2021-05-25
MX348622B (es)	2017-06-22
EP3144318B1 (en)	2020-09-23
FR17C1020I2 (fr)	2020-04-10
HUE030652T2 (en)	2017-05-29
EP3098234B1 (en)	2024-07-31
WO2009127826A1 (en)	2009-10-22
KR20180095140A (ko)	2018-08-24
TWI488640B (zh)	2015-06-21
BRPI0910461B1 (pt)	2021-02-23
JP6486310B2 (ja)	2019-03-20
US9546204B2 (en)	2017-01-17
HRP20170958T1 (hr)	2017-09-22
US20150065695A1 (en)	2015-03-05
MX355457B (es)	2018-04-19
HK1146284A1 (en)	2011-05-20
US8951967B2 (en)	2015-02-10
EP3144318A1 (en)	2017-03-22
JP2011519359A (ja)	2011-07-07
CN105906703A (zh)	2016-08-31
PL2268666T3 (pl)	2014-08-29
EP2808340B1 (en)	2016-08-17
DK3144318T3 (da)	2020-12-07

Publication	Publication Date	Title
FR17C1020I1 (ru)	2020-04-10
BRPI0909040A2 (ru)	2017-09-19
BRPI0908549B8 (ru)	2021-06-08
BRPI0918697A2 (ru)	2017-08-29
BRPI0917525A2 (ru)	2017-07-04
BRPI0920750A2 (ru)	2016-02-02
BRPI0919470A2 (ru)	2017-08-22
BRPI0922455A2 (ru)	2021-12-28
BRPI0917618A8 (ru)	2019-09-10
BRPI0907698A2 (ru)	2017-08-22
BRPI0912727A2 (ru)	2017-08-29
BRPI0923734A2 (ru)	2017-07-11
BRPI0908285A2 (ru)	2017-08-29
BRPI0910485A2 (ru)	2017-08-29
BRPI0922669A2 (ru)	2017-07-11
BRPI0914750A2 (ru)	2017-08-15
BRPI0908120A2 (ru)	2017-08-22
BRPI0904541A8 (ru)	2010-09-21
BRPI0912462A2 (ru)	2016-02-02
BRPI0915616A2 (ru)	2016-02-02
BRPI0919811A2 (ru)	2017-08-29
BRPI0920914A2 (ru)	2017-07-11
BRPI0916284A2 (ru)	2017-08-08
BRPI0922550A2 (ru)	2016-02-02
BRPI0911617A2 (ru)	2017-07-25